Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Poland’s University Technology Transfer Centers: CTT Structure, Spin-Off Law, and the Commercialization Model

How Poland’s university technology transfer centers (CTT) are structured, the legal basis for university spin-off companies via the spolka celowa mechanism, and how the national commercialization framework evolved from the 2005 Law on Higher Education to the 2018 Constitution for Science.

Poland runs one of Central and Eastern Europe’s more developed university technology-transfer systems, organized around campus-based centra transferu technologii (CTTs, “technology transfer centers”) and a specific statutory mechanism for turning research results into spin-off companies. The framework is not a single “spin-off law” passed in one year; it is layered legislation built up mainly between 2005 and 2018, with the current baseline set by the 2018 Law on Higher Education and Science (popularly called the “Constitution for Science” or “Ustawa 2.0”). This guide covers how CTTs are structured, the legal basis for university spin-offs, and how the commercialization model evolved to its current form.

What is a CTT (Centrum Transferu Technologii)?

A CTT is the university unit responsible for moving research results — inventions, know-how, software, materials — toward practical use, functionally equivalent to a technology transfer office (TTO) at a North American or Western European university. Polish CTTs typically handle invention intake, patentability and market screening, IP protection, and negotiating how a result reaches the market, either by licensing/selling rights directly or by helping found a spin-off company around the technology.

Academic technology transfer in Poland dates to the mid-1990s: Wrocław’s technology transfer center, among the first of its kind in the country, was established in 1995, ahead of any comprehensive national legislation on university commercialization. For roughly a decade, individual universities built out transfer capacity without a unified statutory framework — that came later, starting in 2005.

Legal basis: from the 2005 Law on Higher Education to the 2018 “Constitution for Science”

The statutory foundation for university commercialization in Poland is not from 1998. The relevant legislative history runs later, in three main stages:

  • 2005 — Law on Higher Education (Ustawa Prawo o szkolnictwie wyższym, 27 July 2005). This act first gave university commercialization a defined legal structure, distinguishing direct commercialization (selling or licensing research results, know-how, or development work directly to a third party) from indirect commercialization (contributing those results, or acquiring/holding shares, in a company formed to implement them — i.e., a spin-off).
  • 2011 amendment. Introduced the spółka celowa (“special-purpose vehicle” or “special-purpose company”) as a defined instrument: a company a public university may establish specifically to carry out indirect commercialization of its research results, including holding equity in spin-offs on the university’s behalf.
  • 2014 amendment (11 July 2014). Clarified the mechanics of indirect commercialization, in particular that a university (or its spółka celowa) may transfer research results and industrial property rights into a spin-off as an aport — an in-kind (non-cash) capital contribution in exchange for equity, rather than a cash sale.
  • 2018 — Law on Higher Education and Science (Ustawa 2.0 / “Constitution for Science”), 20 July 2018. A comprehensive reform that consolidated and replaced four separate prior laws, including the 2005 Law on Higher Education. It entered into force 1 October 2018, with several provisions phased in over subsequent years, and remains the current governing statute for commercialization, IP ownership, and spin-off formation at Polish public higher-education institutions.

The practical effect: a CASRAI reader researching “Poland’s tech-transfer legal basis” should anchor the framework in 2005 (definitional foundation) and 2018 (current consolidated law), not 1998. If you’ve seen a “post-1998” framing elsewhere, treat it as unverified — it does not match the legislative record found in the Law on Higher Education (2005) or its 2018 successor.

The spin-off / special-purpose-vehicle (spółka celowa) model

Polish law gives a university two commercialization routes for a given research result:

  • Direct commercialization — the university (through its CTT) sells or licenses rights directly to an existing company, keeping the transaction as a straightforward assignment or license agreement.
  • Indirect commercialization — the university forms or uses a spółka celowa to take an equity stake in a newly formed spin-off, typically by contributing the IP itself as an in-kind (aport) contribution rather than cash. The spin-off then commercializes the technology, with the university (via its SPV) holding shares rather than collecting a conventional royalty stream.

This SPV-mediated structure is a distinguishing feature of the Polish (and broader Central/Eastern European) model compared with, for example, the US framework under the Bayh-Dole Act, where a university more commonly licenses IP directly to a spinout founded by faculty, without an intervening statutory holding company. See CASRAI’s Bayh-Dole Act entry and the spin-out vs. spin-off comparison for the terminology and mechanics used elsewhere; note that “spin-off” in Polish legal usage refers specifically to a company formed under this indirect-commercialization/SPV pathway, so the term is used more narrowly in Poland than it is colloquially in English-language tech-transfer writing.

How CTTs are structured within universities

There is no single mandated organizational chart — Polish universities have adopted varying structures — but two patterns are common:

  • An in-house CTT operating as a university administrative unit, handling invention disclosure, IP protection, and direct-licensing negotiations, which then refers indirect-commercialization cases to a separate spółka celowa for equity-based spin-off formation.
  • A more integrated model where the CTT and the spółka celowa work as a single functional pipeline under shared university oversight, with the CTT doing technical/IP triage and the SPV handling the corporate mechanics of forming and capitalizing the spin-off.

Either way, the division of labor mirrors the direct/indirect distinction set in the 2005 and 2018 laws: the CTT is the technical and commercial evaluation function; the spółka celowa is the corporate vehicle used specifically for the equity route.

PACTT — the Polish Association of Centers for Technology Transfer

Polish CTTs coordinate nationally through PACTT (Porozumienie Akademickich Centrów Transferu Technologii), a professional association of university and research-institute technology transfer offices, established in 2015. PACTT functions similarly to AUTM in the United States or ASTP in the broader European context: shared practice standards, training for TTO staff, and a national catalog aggregating member institutions’ available technologies and licensing offers. For the EU-level coordination layer above PACTT, see CASRAI’s guide to EU-wide technology transfer coordination through ASTP and the Knowledge Valorisation Platform.

Ownership of academic IP and inventor rights

Under the current framework, IP arising from research conducted by staff of a public higher-education institution in the course of their employment is generally treated as belonging to the institution, which then chooses the commercialization route (direct or indirect) for a given result. Inventors are entitled to a share of the proceeds when the institution commercializes their work, consistent with the general principle — common across many national systems, not unique to Poland — that academic employers hold commercialization rights subject to a statutory or policy-based revenue share back to the inventor. Exact revenue-share percentages and the finer procedural rules are set at the institutional-policy level under the 2018 law’s framework rather than fixed uniformly by statute, so researchers and administrators should confirm the specific split against their own university’s commercialization regulations rather than assume a single national figure applies everywhere.

How Poland’s model compares to the US Bayh-Dole framework

Feature Poland United States (Bayh-Dole)
Governing statute Law on Higher Education and Science, 2018 (successor to the 2005 Law on Higher Education) Bayh-Dole Act, 1980 (35 U.S.C. 200-212)
Default IP ownership Institution, as employer, for research by academic staff Institution may elect title to inventions made under federal funding
Equity/spin-off route Formal “indirect commercialization” via a statutory spółka celowa (SPV), typically funded through an in-kind IP contribution No equivalent statutory SPV requirement; universities license directly to a spinout, often taking equity by private agreement rather than a mandated vehicle
National coordination body PACTT (est. 2015) AUTM (Association of University Technology Managers)

The two systems solve the same underlying problem — moving publicly funded research into commercial use — but Poland’s reliance on a defined SPV instrument for the equity/spin-off path is a structural difference worth flagging for research administrators comparing international tech-transfer models, for example when benchmarking a US or UK university’s spinout process (see CASRAI’s university spinout companies guide) against a Polish or other EU counterpart.

Frequently asked questions

Is Poland’s university spin-off law based on 1998 legislation?

No. The statutory framework for university commercialization was first defined by the 2005 Law on Higher Education, with the spółka celowa (SPV) mechanism added by a 2011 amendment and clarified in 2014, and the whole area consolidated under the 2018 Law on Higher Education and Science. No primary source supports a 1998 legal basis for this framework.

What is a spółka celowa?

A spółka celowa is a special-purpose company a Polish public university may establish specifically to carry out indirect commercialization — holding equity in spin-off companies formed around university research, typically funded by contributing the underlying IP as an in-kind (aport) contribution rather than cash.

What is the difference between direct and indirect commercialization in Poland?

Direct commercialization is a straightforward sale or license of research results to an existing company. Indirect commercialization routes the result through a spin-off company in which the university (via its spółka celowa) holds equity, rather than collecting a conventional royalty or sale price.

Does every Polish university have its own CTT?

Most research-active public universities and many institutes operate a CTT or equivalent unit; smaller or newer institutions may share transfer capacity, coordinate through PACTT, or rely more heavily on a spółka celowa for the mechanics of spin-off formation. There is no single mandated organizational model.

Who owns inventions made by Polish academic researchers?

As a general rule, IP created by academic staff in the course of their employment at a public institution belongs to the institution, which selects the commercialization route; inventors are entitled to a share of resulting proceeds under institutional policy set within the 2018 law’s framework. The exact revenue-share terms vary by institution.

This guide covers institutional structure and general legal framework, not a specific university’s internal commercialization regulations, tax treatment of in-kind IP contributions, or state-aid/competition-law aspects of university equity stakes — consult your institution’s technology transfer office and, where relevant, Polish legal counsel for those specifics.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →